Endocrines (May 2021)

Vitamin D and Subclinical Cardiovascular Damage in Essential Hypertension

  • Marcello Magurno,
  • Daniele Crescibene,
  • Martina Spinali,
  • Velia Cassano,
  • Giuseppe Armentaro,
  • Keti Barbara,
  • Sofia Miceli,
  • Marta L. Hribal,
  • Maria Perticone,
  • Angela Sciacqua

DOI
https://doi.org/10.3390/endocrines2020013
Journal volume & issue
Vol. 2, no. 2
pp. 133 – 141

Abstract

Read online

Vitamin D deficiency is linked to cardiac dysfunction, vascular remodeling, metabolic syndrome and insulin resistance (IR). The aim of the present study was to evaluate the association between vitamin D levels and cardiovascular (CV) organ damage in a large cohort of newly diagnosed treatment-naïve hypertensive patients, and the role of IR in this context. We enrolled 500 Caucasian individuals, without CV or renal complications. Subjects underwent a complete evaluation and measurements of vitamin D, standard laboratory determinations and instrumental examination, including echocardiography and applanation tonometry. Linear regression analyses were performed to assess the correlation between pulse wave velocity (PWV) and left ventricular mass index (LVMI) with different covariates. PWV was significantly correlated with age (p p p = 0.001), pulse pressure (PP) (p = 0.005) and high sensitivity C-reactive protein (hs-CRP) (p = 0.006), while an inverse correlation was observed with vitamin D levels (p p p = 0.006). LVMI significantly correlated with PP (p p p = 0.001), while an inverse relationship was observed with vitamin D levels (p p p < 0.0001). Vitamin D was the strongest predictor of PWV and LVMI, explaining, respectively, 28.3% and 19.1% of their variation. Our study suggests that low vitamin D might be a biomarker of end-organ damage.

Keywords